Australia markets closed

MedX Health Corp (MDX.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.0850+0.0050 (+6.25%)
At close: 02:48PM EST
Currency in CAD

Valuation measures4

Market cap (intra-day) 14.55M
Enterprise value 16.51M
Trailing P/E N/A
Forward P/E 23.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)22.70
Price/book (mrq)N/A
Enterprise value/revenue 30.44
Enterprise value/EBITDA -4.09

Trading information

Stock price history

Beta (5Y monthly) -0.10
52-week change 3-27.27%
S&P500 52-week change 327.77%
52-week high 30.2600
52-week low 30.0700
50-day moving average 30.1066
200-day moving average 30.1446

Share statistics

Avg vol (3-month) 3205.5k
Avg vol (10-day) 3180.79k
Shares outstanding 5181.91M
Implied shares outstanding 6N/A
Float 8179.99M
% held by insiders 12.00%
% held by institutions 10.56%
Shares short (29 Nov 2021) 4320
Short ratio (29 Nov 2021) 40
Short % of float (29 Nov 2021) 4N/A
Short % of shares outstanding (29 Nov 2021) 40.00%
Shares short (prior month 28 Oct 2021) 419.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sept 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-754.83%

Management effectiveness

Return on assets (ttm)-243.79%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)542.52k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-45.50%
Gross profit (ttm)268.11k
EBITDA -4.11M
Net income avi to common (ttm)-4.48M
Diluted EPS (ttm)-0.0250
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)701.84k
Total cash per share (mrq)0
Total debt (mrq)3.59M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.77
Book value per share (mrq)-0.02

Cash flow statement

Operating cash flow (ttm)-4.11M
Levered free cash flow (ttm)-2.7M